May 15, 2012
Swiss drugmaker Novartis International AG on Monday launched separate patent infringement suits against India-based Lupin Pharmaceuticals Inc. and Torrent Pharmaceuticals Ltd. over their bids to manufacture generic versions of the blood pressure drug Exforge HCT.